Search

Search Constraints

You searched for: Author/Creator Parry, K.

Search Results

1. A phase I dose escalation, safety and pharmacokinetic (PK) study of AZD5312 (IONIS-ARRx), a first-in-class Generation 2.5 antisense oligonucleotide targeting the androgen receptor (AR). (December 2016)

4. Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands. Issue 5 (1st July 2016)

5. Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands. Issue 5 (30th March 2015)